Cardio: Lipid Lowering Agents Flashcards

1
Q

HMG-CoA reductase inhibitor drugs:

A
  • Lovastatin
  • Pravastatin
  • Simvastatin
  • Atorvastatin
  • Rosuvastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Effect of HMG-CoA reductase inhibitors

A
  • ↓↓↓ - LDL
  • ↑ - HDL
  • ↓ - TG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of Action for HMG-CoA reductase inhibitors:

A

Inhibit conversion of HMG-CoA to
mevalonate (a cholesterol precursor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Side Effects of HMG-CoA reductase:

A
  • Hepatotoxicity (↑ LFTs) - minor elevations in serum aminotransferase levels during the 1st month of use: use reduced dosage for patients with hepatic parenchymal disease)
  • Rhabdomyolysis (esp. when used with Fibrates and Niacin)
  • Pregnant women should use Bile acid resins and should never use ‘Statins’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effect of Niacin (Vitamin B3):

A
  • ↓↓ LDL
  • ↑↑ HDL
  • ↓ TG
  • ↓ Lp(a)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of Action of Niacin (Vitamin B3)

A
  • Decreases the production and secretion of VLDL in the Liver
  • Inhibits Lipolysis in Adipose tissue
  • which leads to reduction of Hepatic VLDL synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Side Effects of Niacin (Vitamin B3)

A
  • Red, flushed face (due to PGD2), which is ↓ by aspirin or longterm use
  • Hyperglycemia (Acanthosis Nigricans)
  • Hyperuricemia (exacerbates gout)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bile acid resin (sequestraints) drugs:

A
  • Cholestyramine
  • Colestipol
  • Colesevelam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effect of Bile acid resins:

A
  • ↓↓ LDL
  • Slightly ↑ HDL
  • Slightly ↑ TG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of Bile acid resins:

A
  • Prevent intestinal reabsorption of bile acids
  • Therefore the Liver must use Cholesterol to make more
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side Effects of Bile acid resins:

A
  • Patients HATE IT - it tastes bad and causes GI discomfort
  • ↓ Absorption of Fat-soluble vitamins
  • Cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cholesterol absorption blocking drugs:

A
  • Ezetimibe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of Cholesterol Absoprtion blockers (Ezetimibe)

A
  • ↓↓ LDL
  • No effect HDL
  • No effect TG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of Action of Cholesterol absorption blockers

A
  • Prevent cholesterol absorption at small intestine brush border
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side Effects of Cholesterol absorption blockers

A
  • Rare ↑ LFTs
  • Fatigue, Abdominal pain, and Diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fibrate drugs:

A
  • Gemfibrozil
  • Clofibrate
  • Bezafibrate
  • Fenofibrate
17
Q

Effect of Fibrates:

A
  • ↓ LDL
  • ↑ HDL
  • ↓↓↓ TG
  • They ↓ the incidence of MI and CHD
18
Q

Mechanism of Fibrates:

A
  • Acts as a ligand at Peroxisome Proliferating Activating Receptors - **PPAR-α receptors **
  • Upregulate LPL → ↑ TG clearance → ↑ VLDL and Chylomicron catabolism → ↓ VLDL secretion and by Liver
  • Reduces Hepatic synthesis of Cholesterol
  • Activates PPAR-α to induce HDL synthesis → ↑ ApoA-1 synthesis
19
Q

Side Effects of Fibrates:

A
  • Myositis (↑ risk with concurrent statins)
  • Hepatoxicity (↑ LFTs)
  • Cholesterol gallstones (esp. w/ concurrent Bile acid resins)
20
Q

Cardiac Glycosides drugs:

A
  • Digoxin (Lanoxin)
  • Digitoxin (discontinued in the United States)
  • Ouabain - glycoside plant not used clinically
21
Q

Mechanism of Cardiac glycosides:

A
  • Are carbdenolides that contain a lactone rein and a steroid moiety attached to sugar molecules.
  • Direct inhibition of Na+ / K+ ATPase leads to indirect inhibition of Na+ / Ca2+ exchanger / antiport
  • ↑ [Ca2+] → each action potential produces a greater release of Ca2+→ net result is a positive inotropic effect
  • Increase stroke volume and enhance cardiac output
  • Stimulates Vagus nerve → inhibition of SA node and delayed conduction of AV node → ↓ HR
22
Q

Clinical use of Cardiac glycosides:

A
  • CHF (↑ contractility)
  • Atrial Fibrillation (↓ conduction at AV node and depression of SA node)
  • Administer Potassium-sparing diuretics to avoid Potassium depletion
23
Q

Toxicity of Cardiac glycosides:

A
  • Cholinergic - nausea, vomiting, diarrhea, blurry yellow vision (think of Van Gogh’s Starry Night)
  • ECG - ↑ PR, ↓ QT, ST scooping, T-wave inversion, arrhythmia, AV block
  • Can lead to Hyperkalemia, which indicates poor prognosis
  • Predisposing factors: Renal failure (↓ excretion), Hypokalemia (permissive for digoxin binding at K+ -binding site on Na+ / K+ ATPase) Verapamil, Amiodarone, Quinidine (↓ digoxin clearance; displaces digoxin from tissue-binding sites)